- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Patent holdings for IPC class G01N 33/569
Total number of patents in this class: 11157
10-year publication summary
763
|
761
|
810
|
782
|
768
|
1008
|
1115
|
1020
|
843
|
343
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19803 |
124 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
108 |
Immatics Biotechnologies GmbH | 1152 |
103 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
74 |
Centre National de La Recherche Scientifique | 10311 |
68 |
President and Fellows of Harvard College | 5942 |
68 |
bioMerieux | 926 |
67 |
Institut Pasteur | 789 |
67 |
The General Hospital Corporation | 4701 |
62 |
Labrador Diagnostics LLC | 279 |
61 |
Vanderbilt University | 1886 |
58 |
The Johns Hopkins University | 5637 |
57 |
Denka Company Limited | 2531 |
57 |
Massachusetts Institute of Technology | 10002 |
54 |
Becton, Dickinson and Company | 7225 |
50 |
Board of Regents, The University of Texas System | 5745 |
48 |
Memed Diagnostics Ltd. | 74 |
47 |
IDEXX Laboratories, Inc. | 812 |
44 |
Laboratory Corporation of America Holdings | 822 |
44 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2753 |
43 |
Other owners | 9853 |